验证码已发送至您的邮箱或手机,请查收。
Research Code AV 430A; GW-280430
CAS No.
213998-46-0(Gantacurium chloride)
758669-50-0(GW-0430)
Research Code AV-965
CAS No.
Phase I Active
Research Code AIKO-150; AIKO-151; NTXOL
CAS No.
49625-89-0(6beta-Naltrexol)
Research Code 3-BrPA; NSC-11731; NSC-62343; PSL-001
CAS No.
1113-59-3(Bromopyruvate)
Research Code LT-NS-001; LT-NS001; MX-1094
CAS No.
385800-16-8(Naproxen etemesil)
Phase II Discontinued
A C-C motif chemokine receptor 5 (CCR5) antagonist potentially for the treatment of HIV infection.
Research Code TD-0232
CAS No.
934740-33-7(Nifeviroc)
Phase I Active
Research Code AEOL-10150; Mn-TDEIP
CAS No.
286475-30-7(Aeol 10150)
791770-55-3(AEOL-10150)
Phase III Active
A mitogen-activated protein kinase 8 inhibitor potentially for the treatment of ocular inflammation.
Research Code AM-111
CAS No.
1445179-97-4(Brimapitide)
Phase II Discontinued
Research Code AN-9
CAS No.
122110-53-6(Pivanex)
Phase II Discontinued
Research Code
CAS No.
108560-70-9(Gallium maltolate)
Phase II Active
A vasopressin V2 receptor (AVPR2) agonist potentially for the treatment of nocturia.
Research Code ASP-7035
CAS No.
Research Code XY0206
CAS No.
Research Code HY-021068
CAS No.
Phase I Discontinued
Research Code PUR-118; PUR118
CAS No.
Research Code DTS-108
CAS No.
951792-83-9(DTS-108)
Phase II Discontinued
An immunostimulant potentially for the treatment of influenza virus infections.
Research Code PUR-003
CAS No.
Research Code UNBS-5162
CAS No.
Research Code
CAS No.
935886-64-9(Felbinac Trometamol)
5728-52-9(Felbinac)
Research Code TSF; MC002
CAS No.
1613638-20-2(TSF)
1018438-91-9(TSF Free)
Phase II Active
A phosphodiesterase 5 (PDE5) inhibitor potentially for the treatment of erectile dysfunction (ED).
Research Code
CAS No.
804519-64-0(Yonkenafil Hydrochloride)
804518-63-6(Yonkenafil)
Successful modification
Please choose to cancel the drug